LIFECORE BIOMEDICAL, INC. \DE\ — Form 8-K
Filed September 29, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 18/100
What the filing says
LifeCore Biomedical filed an 8-K on 2026-09-29 reporting entry into a material definitive agreement (Item 1.01) as of 2026-09-24. The filing itself contains no concrete details: no counterparty name, dollar amounts, percentages, share counts, or substantive terms are disclosed in the header or accessible text. The actual agreement details are referenced as exhibits but not provided in this filing extract.
Why this rating
Material agreement announced but zero specifics disclosed here; cannot assess magnitude. Requires exhibit review or press release to gauge true business impact.
Extracted items
- 1.01 material agreement
- 9.01 exhibits
See more from September 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.